Sigrid Jusélius Foundation
5
1
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
Role: collaborator
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
Role: collaborator
HaemoDYNAMICs in Primary and Secondary Hypertension
Role: collaborator
Rye Bread Trial; Antioxidative and Cholesterol Lowering Effects
Role: collaborator
Plasma Pharmacokinetics of Alkylresorcinol Metabolites; New Candidate Biomarkers for Whole Grain Rye and Wheat Intake
Role: collaborator
All 5 trials loaded